Governance

Why does clinical AI need independent release review?

Clinical AI needs independent release review because a model's self-check can repeat its own assumptions and blind spots. Self-checking may flag omissions or contradictions, but release still requires source-data checks, explicit criteria, and a decision by an authorized human reviewer.

A model's self-check can catch obvious omissions, formatting errors, or contradictions, so it can contribute to quality control. It is not independent evidence. When the same model generates a clinical conclusion and then evaluates it, the evaluation can repeat the same missing context, assumptions, or interpretation errors. A high self-score therefore does not establish that the output is ready for release.

Independent release review separates drafting from acceptance. The workflow can apply testable rules, compare the draft with source data, use a separate evaluation where appropriate, preserve the evidence reviewed, and route the result to an authorized clinician. That reviewer must be able to inspect, edit, reject, and document the decision. AI Care Command Center can coordinate configured review stages and audit evidence, while each institution defines its roles and release criteria. AI writes. Doctors decide.

Related questions

Can AI self-review still be useful?+
Yes. It can flag possible omissions or inconsistencies before human review. It should remain one input to the quality process, not the sole authority that releases a clinical output.
What makes a clinical AI review independent?+
The review uses evidence and criteria that do not depend only on the generating model's opinion, such as source-data checks, deterministic rules, separate evaluation, and an authorized human decision.

Micromeet — AI for governed healthcare. MCU CoPilot, AI Scribe (Voice-to-EMR), AI Front Desk, Care Loop, Claim Readiness and AI Care Command Center — every output doctor-reviewed. AI writes. Doctors decide. See the public benchmark →